Ibio Current Deferred Revenue from 2010 to 2024

IBIO Stock  USD 2.64  0.19  7.76%   
Ibio Current Deferred Revenue yearly trend continues to be very stable with very little volatility. Current Deferred Revenue is likely to drop to about 190 K. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2015-03-31
Previous Quarter
200 K
Current Value
400 K
Quarterly Volatility
1.4 M
 
Yuan Drop
 
Covid
Check Ibio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ibio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 163.4 K or Total Revenue of 213.8 K, as well as many indicators such as Price To Sales Ratio of 37.39, Dividend Yield of 0.0662 or PTB Ratio of 0.34. Ibio financial statements analysis is a perfect complement when working with Ibio Valuation or Volatility modules.
  
Check out the analysis of Ibio Correlation against competitors.

Latest Ibio's Current Deferred Revenue Growth Pattern

Below is the plot of the Current Deferred Revenue of Ibio Inc over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Ibio's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ibio's overall financial position and show how it may be relating to other accounts over time.
Current Deferred Revenue10 Years Trend
Slightly volatile
   Current Deferred Revenue   
       Timeline  

Ibio Current Deferred Revenue Regression Statistics

Arithmetic Mean597,867
Geometric Mean143,296
Coefficient Of Variation187.83
Mean Deviation731,920
Median157,000
Standard Deviation1,122,971
Sample Variance1.3T
Range4.2M
R-Value0.42
Mean Square Error1.1T
R-Squared0.17
Significance0.12
Slope104,511
Total Sum of Squares17.7T

Ibio Current Deferred Revenue History

2024190 K
2023200 K
20224.2 M
2021100 K
2020423 K
20191.8 M
20181.3 M

About Ibio Financial Statements

Ibio investors utilize fundamental indicators, such as Current Deferred Revenue, to predict how Ibio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue200 K190 K

Pair Trading with Ibio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ibio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will appreciate offsetting losses from the drop in the long position's value.

Moving against Ibio Stock

  0.67NKTX Nkarta IncPairCorr
  0.67CYRX CryoportPairCorr
  0.63MTEM Molecular TemplatesPairCorr
  0.61MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.56TPST Tempest TherapeuticsPairCorr
The ability to find closely correlated positions to Ibio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ibio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ibio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ibio Inc to buy it.
The correlation of Ibio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ibio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ibio Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ibio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Ibio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ibio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ibio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ibio Inc Stock:
Check out the analysis of Ibio Correlation against competitors.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.03)
Revenue Per Share
0.059
Quarterly Revenue Growth
(0.88)
Return On Assets
(0.30)
Return On Equity
(0.84)
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.